An electrophysiology (EP) laboratory is an operating room or a theatre equipped with high-tech equipment used in the treatment of cardiovascular problems such as arrhythmia, fibrillation, congestive heart failure and stroke among others. EP lab offers patients the opportunity to have their arrhythmia, or irregular heartbeat, tested, diagnosed and treated. An irregular heartbeat can lead to heart complications, fatigue, congestive heart failure or stroke. The EP lab focuses on the electrical function of the heart and treats various conditions on the spot.
Electrophysiology laboratory devices market: Devices
Cardiac mapping can map and detect specific electrical activity of the heart in real time. Any electric irregularities can be immediately diagnosed and potentially treated. Ablation studies can identify a patient’s electrophysiological weaknesses and diagnose diseases to provide suitable preventive measures. This non-surgical, minimally invasive process involves threading a small catheter into the heart. Electric impulses are studied and then potentially blocked or treated to create a regular rhythm in the heart. Defibrillator implantation are for those with a dangerously irregular heart rhythm and a very high risk of cardiac death. In such cases, cardiologists may choose to implant a defibrillator. This device can detect a dangerous rhythm and shock the heart back into regular pace. The device is implanted into a small incision near the heart and connected electrically to the heart. Cardiac electrophysiology assists the diagnosis and treatment of arrhythmias which causes abnormal electrical activities in heart.
Electrophysiology laboratory devices market: WHO report
According to World Health Organization, around 17.5 million people die every year due to cardiovascular diseases. It is expected that, by 2030 about 23 million people may die each year due to cardiovascular diseases. This increasing prevalence of cardiac diseases is expected to boost the electrophysiology market as more and more patients will need medical attention. The prevalence of cardiac diseases is higher in developing nations.
With the potential of 12 million atrial fibrillation patients by the year 2050 and improvements in technology for atrial fibrillation ablation therapy, significant growth is predicted for the number of hospitals building electrophysiology labs. It is estimated that there are about 2,000 electrophysiology labs in the U.S. and 2,000 electrophysiology labs outside the U.S., each with an electrophysiology recording system costing an average of approximately $250,000.
Since past few decades cardiovascular disease prevalence is rising in populated countries such as China and India. Thus indicating a large market in Asia-Pacific in near future. Mobile and modular EP labs are a growing demand due to rise in emergency medicine and unmet on-field military applications. The market for electrophysiology devices is also expected to benefit due to quick adoption of ablation techniques for treating atrial fibrillation. As the technology advances, patients are exposed to less radiation, making it diagnosis and treatment safer for patients.
Electrophysiology laboratory devices market: Key players
Currently University of Rochester Medical Centre, Jeffrey M. Carlton Heart & Vascular Institute, London Bridge Hospital and many others are equipped with electrophysiology laboratory set-up. Corporates are continuously trying to acquire market share in this competitive market. In August 2013, St. Jude acquired Switzerland based Endosense. The deal was valued at USD 331 million, where St. Jude will gain access to TactiCath technology. In November 2013, Boston Scientific completed acquisition of C.R. Bard’s electrophysiology business. Other players in the market include Philips Healthcare, Medtronic, Inc., and GE Healthcare.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.